Specific management issues | Right Decisions

Right Decisions
Asthma pathway (BTS, NICE, SIGN) [SIGN 244]
Back
Managing difficult and severe asthma
Specific management issues

Update your RDS mobile app to v4.7.2 to download toolkits even when website is down.

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. You will see that each toolkit has a small QR code icon in the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively update to the latest release - RDS app version 4.7.1 - to see this improvement.

Updating to this latest version of the RDS app is also strongly recommended to get the full benefits of the new resilience arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

This content is from the BTS/SIGN British guideline on the management of asthma (SIGN 158), 2019.

Allergic bronchopulmonary aspergillosis

R

In adult patients with allergic bronchopulmonary aspergillosis, a four-month trial of itraconazole should be considered.

[BTS/SIGN 2019]

Careful monitoring for side effects, particularly hepatic, is recommended.

[BTS/SIGN 2019]

Beta blockers

Beta blockers, including eye drops, are contraindicated in patients with asthma. Current guidance can be found in the British National Formulary.⁴

References

4. Committee. JF. British National Formulary (online). London: BMJ Group and Pharmaceutical Press; Available from http://www.medicinescomplete.com: [Accessed 17 July 2019].
416. Eccles M, Rousseau N, Higgins B, Thomas L. Evidence-based guideline on the primary care management of asthma. Fam Pract 2001;18(2):223-9.
511. Raissy HH, Harkins M, Kelly F, Kelly HW. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children. Pharmacotherapy 2008;28(3):287-94.